메뉴 건너뛰기




Volumn 28, Issue 13, 2017, Pages 1352-1359

Emerging sexually transmitted viral infections: 1. Review of Ebola virus disease

Author keywords

Africa; Ebola virus; epidemiology; Europe; sexual intercourse; sexually transmitted infection; treatment; World Health Organization

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; EBOLA VACCINE; FAVIPIRAVIR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; REMDESIVIR; VIRAL PROTEIN; VIRUS ANTIGEN; ZMAPP; VIRUS RNA;

EID: 85031397596     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462417703572     Document Type: Review
Times cited : (5)

References (58)
  • 1
    • 84907423943 scopus 로고    scopus 로고
    • Ebola virus disease—current knowledge
    • Kanapathipillai R. Ebola virus disease—current knowledge. N Engl J Med 2014; 371: e18–e18.
    • (2014) N Engl J Med , vol.371 , pp. e18
    • Kanapathipillai, R.1
  • 2
    • 10744231342 scopus 로고    scopus 로고
    • Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda
    • Francesconi P, Yoti Z, Declich S, Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 2003; 9: 1430–1437.
    • (2003) Emerg Infect Dis , vol.9 , pp. 1430-1437
    • Francesconi, P.1    Yoti, Z.2    Declich, S.3
  • 3
    • 84931452346 scopus 로고    scopus 로고
    • Ebola virus stability on surfaces and in fluids in simulated outbreak environments
    • Fischer R, Judson S, Miazgowicz K, Ebola virus stability on surfaces and in fluids in simulated outbreak environments. Emerg Infect Dis 2015; 21: 1243–1246.
    • (2015) Emerg Infect Dis , vol.21 , pp. 1243-1246
    • Fischer, R.1    Judson, S.2    Miazgowicz, K.3
  • 4
    • 0029116432 scopus 로고
    • Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus
    • Johnson E, Jaax N, White J, Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 1995; 76: 227–236.
    • (1995) Int J Exp Pathol , vol.76 , pp. 227-236
    • Johnson, E.1    Jaax, N.2    White, J.3
  • 5
    • 80052345449 scopus 로고    scopus 로고
    • Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology
    • Reed DS, Lackemeyer MG, Garza NL, Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microbes Infect 2011; 13: 930–936.
    • (2011) Microbes Infect , vol.13 , pp. 930-936
    • Reed, D.S.1    Lackemeyer, M.G.2    Garza, N.L.3
  • 6
    • 84922367108 scopus 로고    scopus 로고
    • Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus
    • Baize S. Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus. Curr Opin Virol 2015; 10: 70–76.
    • (2015) Curr Opin Virol , vol.10 , pp. 70-76
    • Baize, S.1
  • 7
    • 85031432702 scopus 로고    scopus 로고
    • World Health Organization. Ebola situation report—30 March 2016, (accessed 1 October 2016)
    • World Health Organization. Ebola situation report—30 March 2016, http://apps.who.int/ebola/current-situation/ebola-situation-report-30-march-2016 (accessed 1 October 2016)
  • 8
    • 84908072433 scopus 로고    scopus 로고
    • Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections
    • WHO Ebola Response Team. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med 2014; 371: 1481–1495
    • (2014) N Engl J Med , vol.371 , pp. 1481-1495
  • 9
    • 84908457460 scopus 로고    scopus 로고
    • Estimating the future number of cases in the Ebola epidemic—Liberia and Sierra Leone, 2014–2015
    • Meltzer MI, Atkins CY, Santibanez S, Estimating the future number of cases in the Ebola epidemic—Liberia and Sierra Leone, 2014–2015. MMWR Suppl 2014; 63: 1–14.
    • (2014) MMWR Suppl , vol.63 , pp. 1-14
    • Meltzer, M.I.1    Atkins, C.Y.2    Santibanez, S.3
  • 10
    • 84907193791 scopus 로고    scopus 로고
    • Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
    • Gire SK, Goba A, Andersen KG, Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014; 345: 1369–1372.
    • (2014) Science , vol.345 , pp. 1369-1372
    • Gire, S.K.1    Goba, A.2    Andersen, K.G.3
  • 11
    • 0032993303 scopus 로고    scopus 로고
    • Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit
    • Rowe AK, Bertolli J, Khan AS, Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 1999; 179: S28–S35.
    • (1999) J Infect Dis , vol.179 , pp. S28-S35
    • Rowe, A.K.1    Bertolli, J.2    Khan, A.S.3
  • 12
    • 77949407840 scopus 로고    scopus 로고
    • High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon
    • Becquart P, Wauquier N, Mahlakoiv T, High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One 2010; 5: e9126–e9126.
    • (2010) PLoS One , vol.5 , pp. e9126
    • Becquart, P.1    Wauquier, N.2    Mahlakoiv, T.3
  • 13
    • 0022001237 scopus 로고
    • Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire
    • Biggar RJ, Melbye M, Kestens L, Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire. Br Med J (Clin Res Ed) 1985; 290: 808–810.
    • (1985) Br Med J (Clin Res Ed) , vol.290 , pp. 808-810
    • Biggar, R.J.1    Melbye, M.2    Kestens, L.3
  • 14
    • 85008323947 scopus 로고    scopus 로고
    • Development of a sensitive and specific serological assay based on luminex technology for detection of antibodies to Zaire Ebola virus
    • Ayouba A, Toure A, Butel C, Development of a sensitive and specific serological assay based on luminex technology for detection of antibodies to Zaire Ebola virus. J Clin Microbiol 2017; 55: 165–176.
    • (2017) J Clin Microbiol , vol.55 , pp. 165-176
    • Ayouba, A.1    Toure, A.2    Butel, C.3
  • 15
    • 84959017828 scopus 로고    scopus 로고
    • Clinical management of Ebola virus disease in the United States and Europe
    • Uyeki TM, Mehta AK, Davey RT, Jr Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med 2016; 374: 636–646.
    • (2016) N Engl J Med , vol.374 , pp. 636-646
    • Uyeki, T.M.1    Mehta, A.K.2    Davey, R.T.3
  • 16
    • 12144288615 scopus 로고    scopus 로고
    • Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome
    • Towner JS, Rollin PE, Bausch DG, Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78: 4330–4341.
    • (2004) J Virol , vol.78 , pp. 4330-4341
    • Towner, J.S.1    Rollin, P.E.2    Bausch, D.G.3
  • 17
    • 84978906705 scopus 로고    scopus 로고
    • Diagnosis of Ebola virus disease: past, present, and future
    • Broadhurst MJ, Brooks TJ, Pollock NR. Diagnosis of Ebola virus disease: past, present, and future. Clin Microbiol Rev 2016; 29: 773–793.
    • (2016) Clin Microbiol Rev , vol.29 , pp. 773-793
    • Broadhurst, M.J.1    Brooks, T.J.2    Pollock, N.R.3
  • 18
    • 85031424674 scopus 로고    scopus 로고
    • Centres for disease control and prevention Ebola virus treatment, (accessed 2 October 2016)
    • Centres for disease control and prevention Ebola virus treatment, http://www.cdc.gov/vhf/Ebola/treatment/ (accessed 2 October 2016)
  • 19
    • 84912539213 scopus 로고    scopus 로고
    • Clinical illness and outcomes in patients with Ebola in Sierra Leone
    • Schieffelin JS, Shaffer JG, Goba A, Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014; 371: 2092–2100.
    • (2014) N Engl J Med , vol.371 , pp. 2092-2100
    • Schieffelin, J.S.1    Shaffer, J.G.2    Goba, A.3
  • 20
    • 84942299591 scopus 로고    scopus 로고
    • Relationship between Ebola virus real-time quantitative polymerase chain reaction-based threshold cycle value and virus isolation from human plasma
    • Spengler JR, McElroy AK, Harmon JR, Relationship between Ebola virus real-time quantitative polymerase chain reaction-based threshold cycle value and virus isolation from human plasma. J Infect Dis 2015; 212: S346–S349.
    • (2015) J Infect Dis , vol.212 , pp. S346-S349
    • Spengler, J.R.1    McElroy, A.K.2    Harmon, J.R.3
  • 21
    • 84991259720 scopus 로고    scopus 로고
    • A randomized, controlled trial of ZMapp for Ebola virus infection
    • Davey RT, Jr Dodd L, Proschan MA, A randomized, controlled trial of ZMapp for Ebola virus infection. N Engl J Med 2016; 375: 1448–1456.
    • (2016) N Engl J Med , vol.375 , pp. 1448-1456
    • Davey, R.T.1    Dodd, L.2    Proschan, M.A.3
  • 22
    • 84954049384 scopus 로고    scopus 로고
    • Evaluation of convalescent plasma for Ebola virus disease in Guinea
    • van Griensven J, Edwards T, de Lamballerie X, Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med 2016; 374: 33–42.
    • (2016) N Engl J Med , vol.374 , pp. 33-42
    • van Griensven, J.1    Edwards, T.2    de Lamballerie, X.3
  • 23
    • 85002487975 scopus 로고    scopus 로고
    • Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies
    • van Griensven J, Edwards T, Baize S. Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies. N Engl J Med 2016; 375: 2307–2309.
    • (2016) N Engl J Med , vol.375 , pp. 2307-2309
    • van Griensven, J.1    Edwards, T.2    Baize, S.3
  • 24
    • 84975452180 scopus 로고    scopus 로고
    • Convalescent plasma for Ebola virus disease
    • Arribas JR, Luczkowiak J, Delgado R. Convalescent plasma for Ebola virus disease. N Engl J Med 2016; 374: 2498–2499.
    • (2016) N Engl J Med , vol.374 , pp. 2498-2499
    • Arribas, J.R.1    Luczkowiak, J.2    Delgado, R.3
  • 25
    • 84982234143 scopus 로고    scopus 로고
    • Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
    • Warren TK, Jordan R, Lo MK, Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 2016; 531: 381–385.
    • (2016) Nature , vol.531 , pp. 381-385
    • Warren, T.K.1    Jordan, R.2    Lo, M.K.3
  • 26
    • 85031415448 scopus 로고    scopus 로고
    • GS-5734 to assess the antiviral activity, longer-term clearance of Ebola Virus, and safety in male ebola survivors with evidence of Ebola virus persistence in semen. (accessed 29 January 2017)
    • GS-5734 to assess the antiviral activity, longer-term clearance of Ebola Virus, and safety in male ebola survivors with evidence of Ebola virus persistence in semen. https://clinicaltrials.gov/ct2/show/NCT02818582 (accessed 29 January 2017)
  • 27
    • 85017391369 scopus 로고    scopus 로고
    • First newborn baby to receive experimental therapies survives Ebola virus disease
    • Epub ahead of print 9 January 2017
    • Dornemann J, Burzio C, Ronsse A, First newborn baby to receive experimental therapies survives Ebola virus disease. J Infect Dis Epub ahead of print 9 January 2017. doi: 10.1093/infdis/jiw493.
    • J Infect Dis
    • Dornemann, J.1    Burzio, C.2    Ronsse, A.3
  • 28
    • 84940952795 scopus 로고    scopus 로고
    • Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
    • Henao-Restrepo AM, Longini IM, Egger M, Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015; 386: 857–866.
    • (2015) Lancet , vol.386 , pp. 857-866
    • Henao-Restrepo, A.M.1    Longini, I.M.2    Egger, M.3
  • 29
    • 85010755634 scopus 로고    scopus 로고
    • Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)
    • Henao-Restrepo AM, Camacho A, Longini IM, Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!). Lancet 2017; 389: 505–518.
    • (2017) Lancet , vol.389 , pp. 505-518
    • Henao-Restrepo, A.M.1    Camacho, A.2    Longini, I.M.3
  • 30
    • 85031400029 scopus 로고    scopus 로고
    • WHO. Ebola virus disease. Updated January 2016, (accessed 2 October 2016)
    • WHO. Ebola virus disease. Updated January 2016, http://www.who.int/mediacentre/factsheets/fs103/en/ (accessed 2 October 2016)
  • 31
    • 84945442885 scopus 로고    scopus 로고
    • Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study
    • Hunt L, Gupta-Wright A, Simms V, Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis 2015; 15: 1292–1299.
    • (2015) Lancet Infect Dis , vol.15 , pp. 1292-1299
    • Hunt, L.1    Gupta-Wright, A.2    Simms, V.3
  • 32
    • 85020591040 scopus 로고    scopus 로고
    • Characteristics and outcomes of pediatric patients with Ebola virus disease admitted to treatment units in Liberia and Sierra Leone: a retrospective cohort study
    • Smit MA, Michelow IC, Glavis-Bloom J, Characteristics and outcomes of pediatric patients with Ebola virus disease admitted to treatment units in Liberia and Sierra Leone: a retrospective cohort study. Clin Infect Dis 2017; 64: 243–249.
    • (2017) Clin Infect Dis , vol.64 , pp. 243-249
    • Smit, M.A.1    Michelow, I.C.2    Glavis-Bloom, J.3
  • 33
    • 67650686813 scopus 로고    scopus 로고
    • Immunoglobulin G in Ebola outbreak survivors, Gabon
    • Wauquier N, Becquart P, Gasquet C, Immunoglobulin G in Ebola outbreak survivors, Gabon. Emerg Infect Dis 2009; 15: 1136–1137.
    • (2009) Emerg Infect Dis , vol.15 , pp. 1136-1137
    • Wauquier, N.1    Becquart, P.2    Gasquet, C.3
  • 34
    • 84959179767 scopus 로고    scopus 로고
    • Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study
    • Mattia JG, Vandy MJ, Chang JC, Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis 2016; 16: 331–338.
    • (2016) Lancet Infect Dis , vol.16 , pp. 331-338
    • Mattia, J.G.1    Vandy, M.J.2    Chang, J.C.3
  • 35
    • 84937726102 scopus 로고    scopus 로고
    • Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study
    • Clark DV, Kibuuka H, Millard M, Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis 2015; 15: 905–912.
    • (2015) Lancet Infect Dis , vol.15 , pp. 905-912
    • Clark, D.V.1    Kibuuka, H.2    Millard, M.3
  • 36
    • 84962610881 scopus 로고    scopus 로고
    • Sequelae of Ebola virus disease: the emergency within the emergency
    • Vetter P, Kaiser L, Schibler M, Sequelae of Ebola virus disease: the emergency within the emergency. Lancet Infect Dis 2016; 16: e82–e91.
    • (2016) Lancet Infect Dis , vol.16 , pp. e82-e91
    • Vetter, P.1    Kaiser, L.2    Schibler, M.3
  • 37
    • 85018193000 scopus 로고    scopus 로고
    • Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study
    • Epub ahead of print 14 January 2017
    • Etard JF, Sow MS, Leroy S, Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study. Lancet Infect Dis Epub ahead of print 14 January 2017. DOI: 10.1016/S1473-3099(16)30516-3.
    • Lancet Infect Dis
    • Etard, J.F.1    Sow, M.S.2    Leroy, S.3
  • 38
    • 84971578877 scopus 로고    scopus 로고
    • Ebola virus disease complications as experienced by survivors in Sierra Leone
    • Tiffany A, Vetter P, Mattia J, Ebola virus disease complications as experienced by survivors in Sierra Leone. Clin Infect Dis 2016; 62: 1360–1366.
    • (2016) Clin Infect Dis , vol.62 , pp. 1360-1366
    • Tiffany, A.1    Vetter, P.2    Mattia, J.3
  • 40
    • 84931393635 scopus 로고    scopus 로고
    • Persistence of Ebola virus in ocular fluid during convalescence
    • Varkey JB, Shantha JG, Crozier I, Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 2015; 372: 2423–2427.
    • (2015) N Engl J Med , vol.372 , pp. 2423-2427
    • Varkey, J.B.1    Shantha, J.G.2    Crozier, I.3
  • 41
    • 0033030820 scopus 로고    scopus 로고
    • Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995
    • Rodriguez LL, De Roo A, Guimard Y, Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179: S170–S176.
    • (1999) J Infect Dis , vol.179 , pp. S170-S176
    • Rodriguez, L.L.1    De Roo, A.2    Guimard, Y.3
  • 42
    • 38449087271 scopus 로고    scopus 로고
    • Assessment of the risk of Ebola virus transmission from bodily fluids and fomites
    • Bausch DG, Towner JS, Dowell SF, Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007; 196: S142–S147.
    • (2007) J Infect Dis , vol.196 , pp. S142-S147
    • Bausch, D.G.1    Towner, J.S.2    Dowell, S.F.3
  • 43
    • 84912539212 scopus 로고    scopus 로고
    • A case of severe Ebola virus infection complicated by gram-negative septicemia
    • Kreuels B, Wichmann D, Emmerich P, A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 2014; 371: 2394–2401.
    • (2014) N Engl J Med , vol.371 , pp. 2394-2401
    • Kreuels, B.1    Wichmann, D.2    Emmerich, P.3
  • 44
    • 85031034733 scopus 로고    scopus 로고
    • Ebola RNA Persistence in semen of Ebola virus disease survivors – preliminary report
    • Epub ahead of print 14 October 2015
    • Deen GF, Knust B, Broutet N, Ebola RNA Persistence in semen of Ebola virus disease survivors – preliminary report. N Engl J Med Epub ahead of print 14 October 2015. DOI: 10.1056/NEJMoa1511410.
    • N Engl J Med
    • Deen, G.F.1    Knust, B.2    Broutet, N.3
  • 45
    • 84931323201 scopus 로고    scopus 로고
    • Shedding of Ebola virus in an asymptomatic pregnant woman
    • Akerlund E, Prescott J, Tampellini L. Shedding of Ebola virus in an asymptomatic pregnant woman. N Engl J Med 2015; 372: 2467–2469.
    • (2015) N Engl J Med , vol.372 , pp. 2467-2469
    • Akerlund, E.1    Prescott, J.2    Tampellini, L.3
  • 46
    • 84949591177 scopus 로고    scopus 로고
    • Live neonates born to mothers with Ebola virus disease: a review of the literature
    • Nelson JM, Griese SE, Goodman AB, Live neonates born to mothers with Ebola virus disease: a review of the literature. J Perinatol 2016; 36: 411–414.
    • (2016) J Perinatol , vol.36 , pp. 411-414
    • Nelson, J.M.1    Griese, S.E.2    Goodman, A.B.3
  • 47
    • 84979533002 scopus 로고    scopus 로고
    • Late Ebola virus relapse causing meningoencephalitis: a case report
    • Jacobs M, Rodger A, Bell DJ, Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 2016; 388: 498–503.
    • (2016) Lancet , vol.388 , pp. 498-503
    • Jacobs, M.1    Rodger, A.2    Bell, D.J.3
  • 48
    • 84948392889 scopus 로고    scopus 로고
    • Ebola: hidden reservoirs
    • Heeney JL. Ebola: hidden reservoirs. Nature 2015; 527: 453–455.
    • (2015) Nature , vol.527 , pp. 453-455
    • Heeney, J.L.1
  • 49
    • 85031429358 scopus 로고    scopus 로고
    • World Health Organisation. Ebola surivivors clinic opens in Monrovia. (accessed 27 January 2017)
    • World Health Organisation. Ebola surivivors clinic opens in Monrovia. http://www.who.int/features/2015/ebola-survivors-clinic/en/ (accessed 27 January 2017).
  • 50
    • 84954545875 scopus 로고    scopus 로고
    • Recurrence and reinfection—a new paradigm for the management of Ebola virus disease
    • MacIntyre CR, Chughtai AA. Recurrence and reinfection—a new paradigm for the management of Ebola virus disease. Int J Infect Dis 2016; 43: 58–61.
    • (2016) Int J Infect Dis , vol.43 , pp. 58-61
    • MacIntyre, C.R.1    Chughtai, A.A.2
  • 51
    • 84990960879 scopus 로고    scopus 로고
    • Ebola virus shedding and transmission: review of current evidence
    • Vetter P, Fischer WA, 2nd Schibler M, Ebola virus shedding and transmission: review of current evidence. J Infect Dis 2016; 214: S177–S184.
    • (2016) J Infect Dis , vol.214 , pp. S177-S184
    • Vetter, P.1    Fischer, W.A.2    Schibler, M.3
  • 52
    • 84994399203 scopus 로고    scopus 로고
    • Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days
    • Diallo B, Sissoko D, Loman NJ, Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis 2016; 63: 1353–1356.
    • (2016) Clin Infect Dis , vol.63 , pp. 1353-1356
    • Diallo, B.1    Sissoko, D.2    Loman, N.J.3
  • 53
    • 84991571506 scopus 로고    scopus 로고
    • Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data
    • Soka MJ, Choi MJ, Baller A, Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data. Lancet Global Health 2016; 4: e736–s743.
    • (2016) Lancet Global Health , vol.4 , pp. e736-s743
    • Soka, M.J.1    Choi, M.J.2    Baller, A.3
  • 55
    • 84949460157 scopus 로고    scopus 로고
    • Molecular evidence of sexual transmission of Ebola virus
    • Mate SE, Kugelman JR, Nyenswah TG, Molecular evidence of sexual transmission of Ebola virus. N Engl J Med 2015; 373: 2448–2454.
    • (2015) N Engl J Med , vol.373 , pp. 2448-2454
    • Mate, S.E.1    Kugelman, J.R.2    Nyenswah, T.G.3
  • 56
    • 85031418149 scopus 로고    scopus 로고
    • World Health Organisation. Emergencies preparedness, response. Frequently asked questions on Ebola Virus. (accessed 28 January 2017)
    • World Health Organisation. Emergencies preparedness, response. Frequently asked questions on Ebola Virus. http://www.who.int/csr/disease/ebola/faq-ebola/en/ (accessed 28 January 2017).
  • 57
    • 84988345446 scopus 로고    scopus 로고
    • Implementation of a national semen testing and counseling program for male Ebola survivors – Liberia, 2015–2016
    • Purpura LJ, Soka M, Baller A, Implementation of a national semen testing and counseling program for male Ebola survivors – Liberia, 2015–2016. MMWR Morb Mortal Wkly Rep 2016; 65: 963–966.
    • (2016) MMWR Morb Mortal Wkly Rep , vol.65 , pp. 963-966
    • Purpura, L.J.1    Soka, M.2    Baller, A.3
  • 58
    • 85019913685 scopus 로고    scopus 로고
    • Validation of the Cepheid Genexpert for detecting Ebola virus in semen
    • Loftis AJ, Quellie S, Chason K, Validation of the Cepheid Genexpert for detecting Ebola virus in semen. J Infect Dis 2017; 215: 344–350.
    • (2017) J Infect Dis , vol.215 , pp. 344-350
    • Loftis, A.J.1    Quellie, S.2    Chason, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.